Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders

Authors
Publication date
1 January 2008
Publisher
Haverford Scholarship

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Haverford College: Haverford Scholarship

    redirect
    oaioai:scholarship.haverford.edu:...
    Last time updated on 17/10/2019